New award for pegfilgrastim with coherus biosciences, INC. Ordering period is april 11, 2025, to april 10, 2026, with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79725D0014
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 78% complete
IDV ceiling
$27,626,788.30
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Accord Biopharma, Inc. for Pegfilgrastim on April 11, 2025, with a ceiling value of $27,626,788.30. The contract implements EO 14398 regarding discrimination and diversity initiatives.

Place of performance encompasses the VA (including Consolidated Mail Order Pharmacies and State Veterans Homes), Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The originating solicitation sought unrestricted procurement of Pegfilgrastim, a pharmaceutical product, with offerors required to provide an uninterrupted source of supply and hold a unique NDC number and label for the product. Estimated annual usage was 8,458 units in syringe or autoinjector form.

The contract runs from April 11, 2025, through April 10, 2026 (base period), with four one-year option periods extending through April 10, 2030. NAICS code 325412 (Pharmaceutical Preparation Manufacturing) applies. No set-aside was used; the procurement was open to all responsible sources.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · Implementing EO 14398 DEI discrimination $0
Supplemental Agreement for work within scope P00005 · This modification is issued to incorporate an NDC addition and deletion into national contract 36E79725D0014. $0
Add Subcontract Plan P00006 · This modification is issued to incorporate accord biopharma INC's 2026 subcontracting plan for the period of april 1, 2026 to march 31, 2027 into national… $0
Novation Agreement P00004 · This modification is issued to incorporate a novation agreement into national contract 36E79725D0014. $0
Exercise an Option P00003 · This modification is issued to exercise option year 1 on NC 36E79725D0014 with a period of performance of 4/11/2026 to 4/10/2027. $0
Supplemental Agreement for work within scope P00002 · This modification is issued to incorporate an NDC addition into NC 36E79725D0014. $0
Other Administrative Action P00001 · This modification is issued to incorporate 2026 federal ceiling prices for NC 36E79725D0014. $0
Original award $0

Quick answers

Who was awarded contract 36E79725D0014?

36E79725D0014 was awarded to Accord Biopharma, Inc. by National Acquisition Center (Headquarters) on April 11, 2025.

How much is contract 36E79725D0014 worth?

36E79725D0014's own ceiling is $27,626,788.

Who can order from contract 36E79725D0014?

36E79725D0014 is a single award indefinite delivery contract.

Was contract 36E79725D0014 competed?

The extent of competition for 36E79725D0014 was full and open competition. The government received 9 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login